The 5 Stages of Parkinson’s Disease Explained

Written by

in

Parkinson’s disease progresses differently for every person. To help describe how it changes over time, doctors and researchers often use a system called the Hoehn and Yahr scale, which divides the disease into five broad stages. The scale doesn’t predict any individual’s future — but it gives a shared language for talking about where someone is in their disease and what kinds of support tend to help most.

Medical disclaimer. This article is for general information only. Parkinson’s varies enormously from person to person, and the stages described here are a rough framework, not a prediction. Discuss your situation with your own neurologist. See our Medical Disclaimer.

Where the 5 stages come from

The five-stage system was introduced by neurologists Margaret Hoehn and Melvin Yahr in 1967. Over the years it has been refined, and many clinics now use a modified version that splits the early stages further. Today, more detailed scales (like the MDS-UPDRS) are typically used for research and treatment planning, but Hoehn and Yahr remains the most widely understood shorthand because it’s simple.

An important note: not everyone moves through every stage. Some people stay in earlier stages for many years. Treatment, exercise, and care quality can all change how someone experiences the disease.

Stage 1: Mild symptoms on one side

In stage 1, symptoms are usually limited to one side of the body. Tremor, slight tremor of one hand, mild stiffness, or a reduced arm swing on one side might be the first signs. Daily activities are usually not significantly affected, and many people continue working and living independently with little change to their routine.

Other early features can include changes in handwriting (it may start to look smaller), slight changes in posture, or family members noticing a flatter facial expression.

Stage 2: Both sides affected, but balance is preserved

Stage 2 typically starts months to years after stage 1. Symptoms now appear on both sides of the body, although they are often more obvious on the side where they started. Walking may become slower, stiffness may be more noticeable, and tasks like dressing or eating may take longer.

An important feature of stage 2 is that balance is still preserved. A person can usually still walk and turn without losing balance, even if movements are slower and stiffer. Many people in stage 2 continue to live and work independently.

Stage 3: Balance problems appear, but independence is mostly preserved

Stage 3 is often considered a turning point. Bilateral symptoms continue, and now balance is impaired. People may have difficulty turning quickly, recover slowly from a small push, or experience occasional falls. Walking may become more shuffling and posture more stooped.

Most people in stage 3 can still live independently, but daily activities — dressing, eating, bathing — take longer. Fall prevention becomes important. Physical therapy, especially Parkinson-specific programs, can help maintain function. Many people also continue to drive in this stage, though some choose to stop based on safety and clinician input.

Stage 4: Significant disability, but still standing and walking

In stage 4, symptoms are severe enough that a person typically needs help with daily activities. Standing and walking are still possible, but a walker or other assistive device is usually needed for safety. Living alone is generally no longer safe without significant support.

Communication may be affected — voice may become very soft, swallowing may be slower, and handwriting may be hard to read. Non-motor symptoms (sleep, mood, blood pressure changes, cognitive changes) often become more prominent and may need their own treatments.

Stage 5: Most advanced

Stage 5 is the most advanced stage. A person typically uses a wheelchair or is bedbound and needs help with most or all daily activities. Speech and swallowing problems often require speech-language pathology support and specific safety measures. Cognitive symptoms may be more prominent.

At this stage, comprehensive care — including caregiver support, palliative care, and home health services — becomes especially important. Many of the changes can be slowed or managed with careful medical, physical, occupational, and speech therapy.

What the stages don’t tell you

The Hoehn and Yahr scale is useful, but it has limits. It focuses on motor symptoms — tremor, stiffness, walking, balance — and doesn’t fully capture:

  • Non-motor symptoms (sleep problems, mood, blood pressure, cognition), which often shape quality of life more than motor symptoms do. See Non-Motor Symptoms of Parkinson’s Disease.
  • Day-to-day fluctuations. Someone in “stage 3” may move and function very differently at different times of day, depending on medication, sleep, and many other factors.
  • Individual variation. Two people at the same “stage” can have very different lives, depending on which symptoms are most prominent.

This is why modern clinical care relies more on detailed scales like the MDS-UPDRS, which measures motor and non-motor symptoms in more depth — but the simple five-stage idea remains useful for everyday conversations.

What helps at each stage

  • Stage 1–2: Confirming the diagnosis with a neurologist, starting an exercise routine (a major evidence-based help in Parkinson’s), considering medication, organizing trust pages and legal/financial planning early, and learning to track symptoms.
  • Stage 3: Physical therapy (including Parkinson-specific programs), fall-prevention planning, occupational therapy for daily tasks, and careful medication review.
  • Stage 4: Home modifications, assistive devices, expanded caregiver involvement, careful evaluation of non-motor symptoms, and continued exercise tailored to ability. Speech and swallowing therapy may be added.
  • Stage 5: Caregiver support, home health services, comfort-focused care planning, and ongoing review of medications.

Whatever the stage, three things help across the board: a good clinician relationship, regular exercise (within ability), and family or caregiver support.

When to talk to a doctor

If you have Parkinson’s, mention to your neurologist any of the following:

  • New or worsening balance problems, near-falls, or actual falls.
  • A medication that no longer seems to last as long.
  • New non-motor symptoms — sleep, mood, blood pressure, cognition.
  • Difficulty swallowing, frequent choking, or unintended weight loss.
  • Caregiver burnout or care needs that have changed significantly.

Call urgently for sudden severe weakness, sudden trouble speaking, sudden severe imbalance, or sudden confusion — those are not typical Parkinson’s changes and need prompt evaluation.

Frequently asked questions

How fast does Parkinson’s disease progress?

There is no single rate. Many people stay in earlier stages for many years. In general, the tremor-predominant subtype tends to progress more slowly than the akinetic-rigid / PIGD subtype. Treatment, exercise, and overall health all play a role.

Do all people with Parkinson’s reach stage 5?

No. The course is highly individual, and many people never reach the most advanced stage. Other medical conditions also influence the picture, particularly because most people with Parkinson’s are diagnosed later in life.

Can you go backward in stages?

The underlying disease is progressive, but day-to-day function can improve dramatically with the right medication, exercise, and management of other conditions. Some people who were “in stage 3” in terms of falls become much steadier once balance training and medication are optimized.

Why do clinicians use different scales?

Hoehn and Yahr is a simple summary. The MDS-UPDRS is much more detailed and assesses motor and non-motor symptoms in depth — researchers and movement-disorder specialists use it for treatment decisions and clinical trials.

Does staging affect treatment?

Generally, staging gives context, but treatment is tailored to the individual’s symptoms, response to medication, and goals — not to a number on a scale.

Related topics

Sources

  • Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427-442.
  • Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale. Movement Disorders. 2004;19(9):1020-1028.
  • Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). Movement Disorders. 2008;23(15):2129-2170.
  • Parkinson’s Foundation. Stages of Parkinson’s. parkinson.org
  • National Institute of Neurological Disorders and Stroke (NINDS). Parkinson’s Disease. ninds.nih.gov

This article is for general information only and is not medical advice. Please see our Medical Disclaimer and discuss your situation with a qualified clinician.